- Home
- PRTA vs UVSP Comparison
PRTA vs UVSP Comparison
Compare PRTA & UVSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- UVSP
- Stock Information
- Founded
- PRTA 2012
- UVSP 1876
- Country
- PRTA Ireland
- UVSP United States
- Employees
- PRTA N/A
- UVSP N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- UVSP Major Banks
- Sector
- PRTA Health Care
- UVSP Finance
- Exchange
- PRTA Nasdaq
- UVSP Nasdaq
- Market Cap
- PRTA 809.8M
- UVSP 881.8M
- IPO Year
- PRTA N/A
- UVSP 1989
- Fundamental
- Price
- PRTA $6.62
- UVSP $32.26
- Analyst Decision
- PRTA Buy
- UVSP Hold
- Analyst Count
- PRTA 9
- UVSP 3
- Target Price
- PRTA $27.67
- UVSP $29.00
- AVG Volume (30 Days)
- PRTA 1.8M
- UVSP 110.2K
- Earning Date
- PRTA 08-07-2025
- UVSP 07-23-2025
- Dividend Yield
- PRTA N/A
- UVSP 2.73%
- EPS Growth
- PRTA N/A
- UVSP 11.32
- EPS
- PRTA N/A
- UVSP 2.66
- Revenue
- PRTA $137,935,000.00
- UVSP $294,306,000.00
- Revenue This Year
- PRTA N/A
- UVSP $11.24
- Revenue Next Year
- PRTA $119.20
- UVSP $4.30
- P/E Ratio
- PRTA N/A
- UVSP $12.13
- Revenue Growth
- PRTA 54.55
- UVSP 2.88
- 52 Week Low
- PRTA $4.32
- UVSP $21.73
- 52 Week High
- PRTA $25.42
- UVSP $32.86
- Technical
- Relative Strength Index (RSI)
- PRTA 61.36
- UVSP 65.48
- Support Level
- PRTA $5.96
- UVSP $29.98
- Resistance Level
- PRTA $6.59
- UVSP $32.86
- Average True Range (ATR)
- PRTA 0.37
- UVSP 0.81
- MACD
- PRTA 0.16
- UVSP 0.27
- Stochastic Oscillator
- PRTA 98.08
- UVSP 90.13
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
About UVSP Univest Financial Corporation
Univest Financial Corp is engaged in domestic banking services for individuals, businesses, municipalities and non-profit organizations. The bank has three operating segments; Banking segment provides financial services including a full range of banking services such as deposit taking, loan origination, and servicing, mortgage banking, other general banking services, and equipment lease financing, Wealth Management segment offers investment advisory, financial planning, trust and brokerage services, and The Insurance segment includes a full-service insurance brokerage agency offering commercial property and casualty insurance, employee benefits solutions, personal insurance lines and human resources consulting. It generates majority of its revenue from the banking segment.